BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18536822)

  • 1. Angiotensin-converting enzyme inhibitor versus angiotensin 2 receptor antagonist therapy and the influence of angiotensin-converting enzyme gene polymorphism in IgA nephritis.
    Woo KT; Lau YK; Chan CM; Wong KS
    Ann Acad Med Singap; 2008 May; 37(5):372-6. PubMed ID: 18536822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease progression, response to ACEI/ATRA therapy and influence of ACE gene in IgA nephritis.
    Woo KT; Lau YK; Zhao Y; Liu FE; Tan HB; Tan EK; Stephanie FC; Chan CM; Wong KS
    Cell Mol Immunol; 2007 Jun; 4(3):227-32. PubMed ID: 17601378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE gene sequence and nucleotide variants in IgA nephropathy.
    Woo KT; Lau YK; Chan CM; Zhao Y; Tan HB; Liu FE; Fook-Chong S; Wong KS
    Singapore Med J; 2011 Nov; 52(11):824-34. PubMed ID: 22173253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinuria and angiotensin converting enzyme (ACE) gene polymorphism.
    Woo KT; Lau YK
    Ann Acad Med Singap; 2000 May; 29(3):383-7. PubMed ID: 10976394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of angiotensin converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy: IGARAS--a study of 274 Men.
    Frimat L; Philippe C; Maghakian MN; Jonveaux P; DE Ligny BH; Guillemin F; Kessler M
    J Am Soc Nephrol; 2000 Nov; 11(11):2062-2067. PubMed ID: 11053482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
    Woo KT; Lau YK; Wong KS; Chiang GS
    Kidney Int; 2000 Dec; 58(6):2485-91. PubMed ID: 11115082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin system gene polymorphisms: its impact on IgAN and its progression to end-stage renal failure among Chinese in Singapore.
    Lau YK; Woo KT; Choong HL; Zhao Y; Tan HB; Chong SM; Tan EK; Yap HK; Wong KS
    Nephron Physiol; 2004; 97(1):p1-8. PubMed ID: 15153745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus.
    Lee YJ; Tsai JC
    Metabolism; 2001 Nov; 50(11):1346-50. PubMed ID: 11699055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
    Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
    Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease.
    Baboolal K; Ravine D; Daniels J; Williams N; Holmans P; Coles GA; Williams JD
    Kidney Int; 1997 Sep; 52(3):607-13. PubMed ID: 9291178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
    Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
    Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
    Courtney AE; McNamee PT; Nelson WE; Maxwell AP
    Nephrol Dial Transplant; 2006 Dec; 21(12):3550-4. PubMed ID: 16968729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.
    Vegter S; Perna A; Hiddema W; Ruggenenti P; Remuzzi G; Navis G; Postma MJ
    Pharmacogenet Genomics; 2009 Sep; 19(9):695-703. PubMed ID: 19696696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.
    Hunley TE; Julian BA; Phillips JA; Summar ML; Yoshida H; Horn RG; Brown NJ; Fogo A; Ichikawa I; Kon V
    Kidney Int; 1996 Feb; 49(2):571-7. PubMed ID: 8821846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy.
    Syrjänen J; Huang XH; Mustonen J; Koivula T; Lehtimäki T; Pasternack A
    Nephron; 2000 Oct; 86(2):115-21. PubMed ID: 11014979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.
    Yoshida H; Mitarai T; Kawamura T; Kitajima T; Miyazaki Y; Nagasawa R; Kawaguchi Y; Kubo H; Ichikawa I; Sakai O
    J Clin Invest; 1995 Nov; 96(5):2162-9. PubMed ID: 7593601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.
    van der Kleij FG; Schmidt A; Navis GJ; Haas M; Yilmaz N; de Jong PE; Mayer G; de Zeeuw D
    Kidney Int Suppl; 1997 Dec; 63():S23-6. PubMed ID: 9407415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis.
    Yoshioka T; Xu YX; Yoshida H; Shiraga H; Muraki T; Ito K
    Arch Dis Child; 1998 Nov; 79(5):394-9. PubMed ID: 10193250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy.
    Yang Y; Ohta K; Shimizu M; Nakai A; Kasahara Y; Yachie A; Koizumi S
    Clin Nephrol; 2005 Jul; 64(1):35-40. PubMed ID: 16047643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.